FDA Approves SculptraAesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles

Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) approved Sculptra Aesthetic (injectable poly-L-lactic acid) for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles which are treated with the appropriate injection technique in healthy patients.

The details can be read here.